This finding underscores the duality of PARP1: though its hyperactivation supports tumor survival and DNA repair, its inhibition (via PARPi) can promote metastasis, potentially by disrupting cytoskeletal regulation and enhancing cell motility. The gene discussed is PARP1; the disease is neoplasm.